JP2015533822A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533822A5
JP2015533822A5 JP2015534689A JP2015534689A JP2015533822A5 JP 2015533822 A5 JP2015533822 A5 JP 2015533822A5 JP 2015534689 A JP2015534689 A JP 2015534689A JP 2015534689 A JP2015534689 A JP 2015534689A JP 2015533822 A5 JP2015533822 A5 JP 2015533822A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrido
pyrimidin
cyclopropyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015534689A
Other languages
English (en)
Japanese (ja)
Other versions
JP6535430B2 (ja
JP2015533822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/062085 external-priority patent/WO2014052699A1/en
Publication of JP2015533822A publication Critical patent/JP2015533822A/ja
Publication of JP2015533822A5 publication Critical patent/JP2015533822A5/ja
Application granted granted Critical
Publication of JP6535430B2 publication Critical patent/JP6535430B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015534689A 2012-09-28 2013-09-27 非定型プロテインキナーゼcのアザキナゾリン阻害薬 Active JP6535430B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261707340P 2012-09-28 2012-09-28
US61/707,340 2012-09-28
US201361781364P 2013-03-14 2013-03-14
US61/781,364 2013-03-14
PCT/US2013/062085 WO2014052699A1 (en) 2012-09-28 2013-09-27 Azaquinazoline inhibitors of atypical protein kinase c

Publications (3)

Publication Number Publication Date
JP2015533822A JP2015533822A (ja) 2015-11-26
JP2015533822A5 true JP2015533822A5 (cg-RX-API-DMAC7.html) 2017-06-22
JP6535430B2 JP6535430B2 (ja) 2019-06-26

Family

ID=49326872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015534689A Active JP6535430B2 (ja) 2012-09-28 2013-09-27 非定型プロテインキナーゼcのアザキナゾリン阻害薬

Country Status (18)

Country Link
US (2) US9914730B2 (cg-RX-API-DMAC7.html)
EP (1) EP2900666B1 (cg-RX-API-DMAC7.html)
JP (1) JP6535430B2 (cg-RX-API-DMAC7.html)
KR (1) KR102215272B1 (cg-RX-API-DMAC7.html)
CN (1) CN105102456B (cg-RX-API-DMAC7.html)
AU (1) AU2013323360B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015007061B1 (cg-RX-API-DMAC7.html)
CA (1) CA2886495C (cg-RX-API-DMAC7.html)
CL (1) CL2015000781A1 (cg-RX-API-DMAC7.html)
EA (1) EA030253B1 (cg-RX-API-DMAC7.html)
IL (1) IL237918B (cg-RX-API-DMAC7.html)
MX (1) MX372736B (cg-RX-API-DMAC7.html)
NZ (1) NZ706857A (cg-RX-API-DMAC7.html)
PH (1) PH12015500689A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201502301YA (cg-RX-API-DMAC7.html)
TW (1) TWI663165B (cg-RX-API-DMAC7.html)
WO (1) WO2014052699A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201502783B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6535430B2 (ja) * 2012-09-28 2019-06-26 イグニタ、インク. 非定型プロテインキナーゼcのアザキナゾリン阻害薬
US9868707B2 (en) 2012-12-20 2018-01-16 Sanford-Burnham Medical Research Institute Small molecule agonists of neurotensin receptor 1
GEP201706780B (en) 2013-03-14 2017-11-27 Boehringer Ingelheim Int Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
AU2014308616B2 (en) 2013-08-23 2018-12-06 Neupharma, Inc. Certain chemical entities, compositions, and methods
WO2015143376A1 (en) * 2014-03-21 2015-09-24 Nivalis Therapeutics, Inc. Novel compounds for the treatment of cystic fibrosis
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶c之氮雜喹唑啉抑制劑
JP6599908B2 (ja) 2014-06-25 2019-10-30 サンフォード−バーンハム メディカル リサーチ インスティテュート ニューロテンシン受容体1の小分子アゴニスト
AR101106A1 (es) 2014-07-02 2016-11-23 Pharmacyclics Llc Inhibidores de tirosina quinasa de bruton
WO2016037106A1 (en) 2014-09-05 2016-03-10 Allosteros Therapeutics, Inc CaMKII INHIBITORS AND USES THEREOF
CN107074870B (zh) 2014-09-12 2019-07-12 勃林格殷格翰国际有限公司 组织蛋白酶c的螺环化合物抑制剂
WO2016068580A2 (en) * 2014-10-29 2016-05-06 Dong-A Socio Holdings Co., Ltd. Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)
CN105288512A (zh) * 2015-12-08 2016-02-03 李野林 一种治疗肥胖症的中药组合物
US10975056B2 (en) 2016-06-13 2021-04-13 Glaxosmithkline Intellectual Property Development Limited Substituted pyridines as inhibitors of DNMT1
JP7101165B2 (ja) * 2016-08-15 2022-07-14 ニューファーマ, インコーポレイテッド 特定の化学的実体、組成物、および方法
EP3500569B1 (en) * 2016-08-16 2022-05-18 Merck Patent GmbH 2-oxo-imidazopyridines as reversible btk inhibitors and uses thereof
EP3515446B1 (en) 2016-09-19 2023-12-20 Novartis AG Therapeutic combinations comprising a raf inhibitor and a erk inhibitor
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
DK3618875T3 (da) 2017-05-02 2023-07-10 Novartis Ag Kombinationsterapi omfattende en raf-inhibitor og trametinib
KR102469161B1 (ko) 2017-06-30 2022-11-23 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 Rho-관련 단백질 키나아제 억제제, Rho-관련 단백질 키나아제 억제제를 함유하는 약학 조성물, 제조 방법 및 약학 조성물의 용도
KR102563325B1 (ko) 2017-06-30 2023-08-03 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 Rho-관련 단백질 키나아제 억제제, Rho-관련 단백질 키나아제 억제제를 함유하는 약학 조성물, 제조 방법 및 약학 조성물의 용도
AU2018294054B2 (en) 2017-06-30 2022-05-26 Beijing Tide Pharmaceutical Co., Ltd. Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
MY206632A (en) * 2018-07-25 2024-12-27 Faes Farma Sa Pyridopyrimidines as histamine h4-receptor inhibitors
US20210347785A1 (en) * 2018-08-01 2021-11-11 Shanghai Ennovabio Pharmaceuticals Co., Ltd. Preparation and application of aromatic compound having immunoregulatory function
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法
BR112021019204A2 (pt) * 2019-03-28 2021-11-30 Cancer Research Tech Ltd Inibidores da proteína quinase c atípica e o uso dos mesmos no tratamento de cânceres dependente da via de hedgehog
KR102881316B1 (ko) 2019-05-13 2025-11-05 노파르티스 아게 암 치료를 위한 raf 억제제로서의 n-(3-(2-(2-하이드록시에톡시)-6-모르폴리노피리딘-4-일)-4-메틸페닐)-2 (트리플루오로메틸)이소니코틴아미드의 새로운 결정질 형태
CN116120243B (zh) * 2021-11-15 2025-07-29 都创(上海)医药科技股份有限公司 aPKC抑制剂化合物中间体片段及其制备方法和应用
CN114349711B (zh) * 2022-02-28 2023-08-15 四川依维欣医药科技有限公司 一种(R)-1-Boc-3-羟甲基哌嗪的合成方法
CN117088898A (zh) * 2022-05-13 2023-11-21 中国药科大学 稠环嘧啶类化合物及其制备方法、药物组合物和应用
WO2024129737A1 (en) * 2022-12-13 2024-06-20 Varian Biopharmaceuticals, Inc. Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro- pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl}-((s)-3,3-dimethyl-piperidin-4-yl)-amine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4936700A (cg-RX-API-DMAC7.html) 1972-08-16 1974-04-05
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP2002080423A (ja) * 2000-09-06 2002-03-19 Daikin Ind Ltd トリフルオロ酢酸エチルの合成方法
JP2004509115A (ja) 2000-09-15 2004-03-25 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼインヒビターとして有用なピラゾール化合物
FR2846657B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4895806B2 (ja) * 2003-04-09 2012-03-14 エクセリクシス, インク. Tie−2モジュレータと使用方法
US20050038047A1 (en) * 2003-08-14 2005-02-17 Edwards Paul John Azaquinazoline derivatives
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
JP2008531538A (ja) * 2005-02-25 2008-08-14 クドス ファーマシューティカルズ リミテッド 2,4−ジアミノ−ピリドピリミジン誘導体とmTOR阻害剤としてのその使用
BRPI0715888B1 (pt) * 2006-08-23 2021-11-03 Kudos Pharmaceuticals Limited Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto
CA2662768A1 (en) * 2006-09-08 2008-03-20 Pfizer Products Inc. Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
EP2473054B1 (en) * 2009-09-04 2017-06-14 The Regents of the University of Michigan Compositions and methods for treatment of leukemia
JP6535430B2 (ja) * 2012-09-28 2019-06-26 イグニタ、インク. 非定型プロテインキナーゼcのアザキナゾリン阻害薬
BR112015022602A2 (pt) * 2013-03-13 2017-07-18 Univ Michigan Regents composições compreendendo compostos de tienopirimidina e tienopiridina e métodos de uso dos mesmos
WO2016040330A1 (en) * 2014-09-09 2016-03-17 The Regents Of The University Of Michigan Thienopyrimidine and thienopyridine compounds and methods of use thereof
EP3394064A1 (en) * 2015-12-22 2018-10-31 Vitae Pharmaceuticals, Inc. Inhibitors of the menin-mll interaction

Similar Documents

Publication Publication Date Title
JP2015533822A5 (cg-RX-API-DMAC7.html)
AU2013323360B2 (en) Azaquinazoline inhibitors of atypical protein kinase C
AU2019240299B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
JP6336665B2 (ja) Fgfr阻害剤としての置換三環式化合物
EP2558468B1 (en) 5, 7-substituted-imidazo [1,2-c] pyrimidines as inhibitors of jak kinases
JP2024532734A (ja) 複素環式化合物及び使用方法
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
CN117651700A (zh) 2-氨基苯并噻唑化合物及使用方法
WO2024107686A1 (en) Macrocyclic kras inhibitors and methods of use
JP2017518326A5 (cg-RX-API-DMAC7.html)
JP2015521600A5 (cg-RX-API-DMAC7.html)
HRP20160649T1 (hr) Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba
HRP20151442T1 (hr) Spojevi heteroaril piridona i aza-piridona kao inhibitori btk-djelovanja
CA2687035A1 (en) Amino-heterocyclic compounds
JP2011511034A5 (cg-RX-API-DMAC7.html)
JP2015537010A5 (cg-RX-API-DMAC7.html)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
JP2015504057A5 (cg-RX-API-DMAC7.html)
JP2017505327A5 (cg-RX-API-DMAC7.html)
MX2011001196A (es) Compuestos de pirimidina, composiciones y metodos de uso.
US20110152243A1 (en) Novel thienopyrrole compounds
JPWO2019156987A5 (cg-RX-API-DMAC7.html)
WO2025230862A1 (en) Macrocyclic amino compounds as modulators of kras and uses therof
WO2025194057A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
CN117897159A (zh) 杂环化合物及使用方法